Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEP) Cash from Investing Activities (2023 - 2024)

Coeptis Therapeutics Holdings (COEP) has 2 years of Cash from Investing Activities data on record, last reported at $100000.0 in Q4 2024.

  • For Q4 2024, Cash from Investing Activities changed N/A year-over-year to $100000.0; the TTM value through Sep 2025 reached $100000.0, up 200.0%, while the annual FY2021 figure was -$1.8 million, 97.69% up from the prior year.
  • Cash from Investing Activities reached $100000.0 in Q4 2024 per COEP's latest filing, up from -$100000.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $350000.0 in Q3 2023 and bottomed at -$350000.0 in Q2 2023.